<DOC>
	<DOCNO>NCT01391065</DOCNO>
	<brief_summary>The propose two stage study evaluate pattern local recurrence EBRT brachytherapy spatial reference baseline functional MRI FLT/F-Miso PET scan patient undergo chemoradiotherapy postoperative recurrence cervical cancer . The first stage study focus develop MR guide interstitial brachytherapy validate concept high risk gross tumor volume ( basis functional imaging feature ) . The second stage thereafter focus develop biologically modulate interstitial brachytherapy . In proposed two stag study investigator intend prospectively evaluate validate concept HRGTV develop technique biologically dose modulate brachytherapy . The demonstration technical feasibility clinical safety biologically modulate image guide radiotherapy pilot study may pave way improve local control patient postoperative recurrence .</brief_summary>
	<brief_title>MR-PET Guided Biologically Optimised Interstitial Brachytherapy</brief_title>
	<detailed_description>Aims Stage I Aim 1 : To spatially characterize biologically heterogenous subvolumes within gross tumor multimodality ( 18 F-Miso/FLT/Functional MR ) image fusion . Aim 2 : To evaluate post external beam radiotherapy ( EBRT ) response spatial reference biological heterogeneous sub-volumes image . Stage II : Aim 3 : To evaluate technical feasibility deliver dose modulate biologically optimize interstitial brachytherapy . Aim 4 : To evaluate acute late toxicity quality life associate biologically optimize brachytherapy</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year . ECOG 0 1 . Residual/ Recurrent tumor hysterectomy cervical cancer . No visceral metastasis . No known contraindication contrast enhance MRI/PET scan . Fit radical treatment ( radiotherapy+/chemotherapy ) . Expected survival le 3 year due coexist morbid medical condition preclude radical chemoradiotherapy . Inguinal extrapelvic nodal metastasis ( Patients common iliac nodal enlargement absence paraaortic nodal metastasis PETCT may include study ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Diffusion Weighted MRI</keyword>
	<keyword>FLT PET</keyword>
	<keyword>F-Miso PET</keyword>
	<keyword>Image Guided Brachytherapy</keyword>
	<keyword>Cervix</keyword>
	<keyword>Postoperative Residual Disease/Postoperative recurrence</keyword>
</DOC>